Sandbox Reserved 1648: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 22: | Line 22: | ||
- an immunoglobuline-like domain ('''IGD ''' (<scene name='86/868181/Igd/1'>IGD heavy chain</scene> and <scene name='86/868181/Igd/2'>IGD light chain</scene>)) | - an immunoglobuline-like domain ('''IGD ''' (<scene name='86/868181/Igd/1'>IGD heavy chain</scene> and <scene name='86/868181/Igd/2'>IGD light chain</scene>)) | ||
- two additional membrane-proximal fibronectin type III ('''FN III''' <scene name='86/868181/Fn_iii/1'>single FN III domain</scene> or <scene name='86/868181/Fn_iii/2'>Fn III domains</scene>) domains <ref> DOI:https://doi.org/10.1016/j.str.2012.01.019 </ref> <ref name="refl"> </ref>. | - two additional membrane-proximal fibronectin type III ('''FN III''' (<scene name='86/868181/Fn_iii/1'>single FN III domain</scene> or <scene name='86/868181/Fn_iii/2'>Fn III domains</scene>)) domains <ref> DOI:https://doi.org/10.1016/j.str.2012.01.019 </ref> <ref name="refl"> </ref>. | ||
ObR is heavily glycosylated causing an increase of 30-70 kDa in molecular weight <ref name="refl"> </ref> . | ObR is heavily glycosylated causing an increase of 30-70 kDa in molecular weight <ref name="refl"> </ref> . | ||
